PTC Therapeutics
PTCT
#2644
Rank
NZ$11.87 B
Marketcap
NZ$143.12
Share price
-4.23%
Change (1 day)
77.70%
Change (1 year)

PTC Therapeutics (PTCT) - Net assets

Net assets on the balance sheet as of March 2026 : -NZ$0.32 Billion

According to PTC Therapeutics 's latest financial reports the company has -NZ$0.32 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

PTC Therapeutics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-NZ$0.36 Billion-81.79%
2024-12-31$-NZ$1.95 Billion50.42%
2023-12-31$-NZ$1.3 Billion136.77%
2022-12-31$-NZ$0.55 Billion-26066.9%
2021-12-31$NZ$2.1 M-99.68%
2020-12-31$NZ$0.66 B-24.31%
2019-12-31$NZ$0.88 B68.78%
2018-12-31$NZ$0.52 B137.38%
2017-12-31$NZ$0.22 B27.59%
2016-12-31$NZ$0.17 B-47.72%
2015-12-31$NZ$0.33 B-13.32%
2014-12-31$NZ$0.38 B129.26%
2013-12-31$NZ$0.16 B-812.12%
2012-12-31$-NZ$23.34 Million-92.37%
2011-12-31$-NZ$0.31 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
NZ$68.90 B-21,670.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$34.27 B-10,828.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.12 B-452.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$2.66 B-934.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.41 B-229.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$2.98 B-1,035.69%๐Ÿ‡บ๐Ÿ‡ธ USA